Citations

Citations to this article as recorded by  

• Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis
  Vlad Ratziu, Sven Francque, Cynthia A. Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S. Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A. Harrison
  Hepatology.2024; 80(1): 173.     CrossRef
• Classification of the Stages of Nonalcoholic Steatohepatitis via Federated General Visual Representation Learning
  Mehmet Nergiz
  International Journal of Imaging Systems and Technology.2024;[Epub]     CrossRef
• Outcome prediction in metabolic dysfunction‐associated steatotic liver disease using stain‐free digital pathological assessment
  Timothy J. Kendall, Elaine Chng, Yayun Ren, Dean Tai, Gideon Ho, Jonathan A. Fallowfield
  Liver International.2024; 44(10): 2511.     CrossRef
• Chronic polypharmacy, monotherapy, and deprescribing: Understanding complex effects on the hepatic proteome of aging mice
  Kevin Winardi, John Mach, Matthew J. McKay, Mark P. Molloy, Sarah J. Mitchell, Michael R. MacArthur, Catriona McKenzie, David G. Le Couteur, Sarah N. Hilmer
  Aging Cell.2024;[Epub]     CrossRef
• Non-alcoholic fatty liver disease: the pathologist’s perspective
  Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S302.     CrossRef
• CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
  Ha Neul Kim, Hong Jae Jeon, Hei Gwon Choi, In Sun Kwon, Woo Sun Rou, Jeong Eun Lee, Tae Hee Lee, Seok Hyun Kim, Byung Seok Lee, Kyung Sook Shin, Hyun Jung Lee, Hyuk Soo Eun
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
  Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato
  Computational and Structural Biotechnology Journal.2023; 21: 2495.     CrossRef
• An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease
  Timothy J. Kendall, Maria Jimenez-Ramos, Frances Turner, Prakash Ramachandran, Jessica Minnier, Michael D. McColgan, Masood Alam, Harriet Ellis, Donald R. Dunbar, Gabriele Kohnen, Prakash Konanahalli, Karin A. Oien, Lucia Bandiera, Filippo Menolascina, An
  Nature Medicine.2023; 29(11): 2939.     CrossRef
• Improved pathology reporting in NAFLD/NASH for clinical trials
  Caitlin Rose Langford, Marc H Goldinger, Darren Treanor, Clare McGenity, Jonathan R Dillman, Daniela S Allende, Robert Goldin, Elizabeth M Brunt, Kurt Zatloukal, Helmut Denk, Kenneth A Fleming
  Journal of Clinical Pathology.2022; 75(2): 73.     CrossRef
• Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients
  Stefan G. Hübscher, Sandy Feng, Annette S. H. Gouw, Hironori Haga, Hyo Jeong Kang, Deirdre A. Kelly, Mina Komuta, Andrew Lesniak, Benjamin A. Popp, Henkjan J. Verkade, Eunsil Yu, Anthony J. Demetris
  Liver Transplantation.2022; 28(9): 1475.     CrossRef
• Discordant pathological diagnosis of non‐alcoholic fatty liver disease: A prospective multicenter study
  Takuya Kuwashiro, Hirokazu Takahashi, Hideyuki Hyogo, Yuji Ogawa, Kento Imajo, Masato Yoneda, Takashi Nakahara, Satoshi Oeda, Kenichi Tanaka, Yuichiro Amano, Shinji Ogawa, Atsushi Kawaguchi, Shinichi Aishima, Masayoshi Kage, Kazuaki Chayama, Atsushi Nakaj
  JGH Open.2020; 4(3): 497.     CrossRef
• Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns
  Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros
  Metabolism.2020; 104: 154144.     CrossRef
• A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
  Kyoungbun Lee, Eun Sun Jung, Eunsil Yu, Yun Kyung Kang, Mee-Yon Cho, Joon Mee Kim, Woo Sung Moon, Jin Sook Jeong, Cheol Keun Park, Jae-Bok Park, Dae Young Kang, Jin Hee Sohn, So-Young Jin
  Journal of Pathology and Translational Medicine.2020; 54(3): 228.     CrossRef
• An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
  Wei-Qiang Leow, Pierre Bedossa, Feng Liu, Lai Wei, Kiat-Hon Lim, Wei-Keat Wan, Yayun Ren, Jason Pik-Eu Chang, Chee-Kiat Tan, Aileen Wee, George Boon-Bee Goh
  Diagnostics.2020; 10(9): 643.     CrossRef
• Deep learning quantification of percent steatosis in donor liver biopsy frozen sections
  Lulu Sun, Jon N. Marsh, Matthew K. Matlock, Ling Chen, Joseph P. Gaut, Elizabeth M. Brunt, S. Joshua Swamidass, Ta-Chiang Liu
  EBioMedicine.2020; 60: 103029.     CrossRef
• Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease
  Juan S. Calle-Toro, Suraj D. Serai, Erum A. Hartung, David J. Goldberg, Bradley D. Bolster, Kassa Darge, Sudha A. Anupindi
  Abdominal Radiology.2019; 44(3): 894.     CrossRef
• R2 relaxometry based MR imaging for estimation of liver iron content: A comparison between two methods
  Juan S. Calle-Toro, Christian A. Barrera, Dmitry Khrichenko, Hansel J. Otero, Suraj D. Serai
  Abdominal Radiology.2019; 44(9): 3058.     CrossRef
• Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis
  Bernard Fromenty
  Liver Research.2019; 3(3-4): 157.     CrossRef
• Standardising the interpretation of liver biopsies in non‐alcoholic fatty liver disease clinical trials
  Rish K. Pai, David E. Kleiner, John Hart, Oyedele A. Adeyi, Andrew D. Clouston, Cynthia A. Behling, Dhanpat Jain, Sanjay Kakar, Mayur Brahmania, Lawrence Burgart, Kenneth P. Batts, Mark A. Valasek, Michael S. Torbenson, Maha Guindi, Hanlin L. Wang, Veeral
  Alimentary Pharmacology & Therapeutics.2019; 50(10): 1100.     CrossRef
• NAFLD Histology: a Critical Review and Comparison of Scoring Systems
  Rish K. Pai
  Current Hepatology Reports.2019; 18(4): 473.     CrossRef
• Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis
  Michael Estep, Rohini Mehta, Gary Bratthauer, Lakshmi Alaparthi, Fanny Monge, Simon Ali, Dinan Abdelatif, Zahra Younoszai, Maria Stepanova, Zachary D. Goodman, Zobair M. Younossi
  BMC Gastroenterology.2019;[Epub]     CrossRef
• Validation of intimate correlation between visceral fat and hepatic steatosis: Quantitative measurement techniques using CT for area of fat and MR for hepatic steatosis
  Moon Hyung Choi, Joon-Il Choi, Michael Yong Park, Sung Eun Rha, Soon Nam Oh, Seung Eun Jung, Jae Young Byun, Stephan Kannengiesser, Yohan Son
  Clinical Nutrition.2018; 37(1): 214.     CrossRef
• Ultrasound or MR elastography of liver: which one shall I use?
  Meng Yin, Sudhakar K. Venkatesh
  Abdominal Radiology.2018; 43(7): 1546.     CrossRef
• Feasibility and agreement of stiffness measurements using gradient-echo and spin-echo MR elastography sequences in unselected patients undergoing liver MRI
  Guilherme Moura Cunha, Kevin J Glaser, Anke Bergman, Rodrigo P Luz, Eduardo H de Figueiredo, Flavia Paiva Proença Lobo Lopes
  The British Journal of Radiology.2018; : 20180126.     CrossRef
• Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease
  Pik Eu Chang, George Boon Bee Goh, Wei Qiang Leow, Liang Shen, Kiat Hon Lim, Chee Kiat Tan, Manlio Vinciguerra
  PLOS ONE.2018; 13(6): e0199166.     CrossRef